Howard Brown Health Center

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• HIV3 trials

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Gilead Sciences3 trials

Running trials

• Active, not recruiting

  Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

  NCT07047716· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

  NCT05052996· Phase 2· Gilead Sciences· Source

• Active, not recruiting

  Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection

  NCT04925752· Phase 3· Gilead Sciences· Source